TreeENT‘s Three Novel Therapies Help Hong Kong Residents Find Solutions

Bid Farewell to Seasonal Rhinitis Misery: TreeENT's Three Novel Therapies Help Hong Kong Residents Find Solutions

During autumn and winter, Hong Kong experiences significant temperature fluctuations, coupled with active respiratory viruses, exacerbating symptoms for many rhinitis sufferers. Constant sneezing and persistent nasal congestion severely impact daily life. According to data from the Hong Kong Allergy Association, approximately 40% of Hong Kong residents suffer from chronic rhinitis, with nearly 60% of patients reporting limited efficacy from traditional medications and urgently needing more effective solutions.

Professor Lu Yongtian of TreeENT pointed out, "Many rhinitis patients experience noticeable recurrence during sudden temperature changes. If combined with respiratory viral infections, the condition often becomes more severe and prolonged."

Rhinitis as a Hong Kong 'Urban Affliction': Traditional Treatments Reach a Bottleneck

For many Hong Kong residents long plagued by rhinitis, traditional treatment methods are facing clear limitations. The drowsiness and other side effects of oral antihistamines affect daily work and life, while steroid sprays often prove inadequate for stubborn symptoms. More worryingly, due to poor symptom control, many patients successively develop sleep disorders, decreased work efficiency, and even complications such as sinusitis and otitis media, trapping them in the dilemma of "medication being ineffective, but symptoms worsening without it."

Addressing the limitations of traditional treatments, TreeENT integrates advanced international technologies to offer diversified treatment plans, providing personalized solutions for patients with different needs.

TreeENT's Three Precision Therapies Break Through Traditional Treatment Limitations

1.Targeted Biologics: Precisely Blocking the Core Allergy Pathway

TreeENT introduces the new biological targeted agent KEYMEDBIO (Suplukibart Injection), targeting the core of inflammation by blocking key inflammatory signals, thereby controlling both the "fast reaction" (immediate sneezing) and "slow reaction" (persistent congestion) of rhinitis. Clinical studies show that over 70% of patients experience significant symptom improvement within the first week of use, offering a breakthrough treatment option for moderate-to-severe patients.

2.Precision Neuromodulation: Long-term Control of Nasal Allergic Responses

For patients with overly sensitive nerves, the "Rhinitis Injection" (Sphenopalatine Ganglion Block) utilizes endoscopic visualization for precise positioning to regulate the sphenopalatine ganglion, which controls nasal secretions, thereby reducing the nasal cavity's overreaction to external stimuli. Clinical observations indicate that most treated patients experience significant reduction in runny nose and sneezing symptoms, with effect duration prolonged compared to traditional cervical injections.

3.Minimally Invasive Surgical Intervention: New Hope for Severe Patients

For patients with refractory severe symptoms, sphenopalatine ganglion branch block surgery becomes a new hope. Guided by high-definition imaging systems, it precisely severs the nerve branches governing nasal secretion and vasodilation, fundamentally reducing nasal allergic responses. The procedure is minimally invasive, involves minimal bleeding, allows quick recovery, and typically enables a return to normal life shortly after surgery. Professor Lu also mentioned: "Many patients also have comorbid issues such as rhinogenic headache and sleep apnea. We fully consider these correlations when designing minimally invasive surgical plans, allowing us to address patients' multi-level problems simultaneously in a single surgery. Long-term follow-up data shows durable and stable efficacy, with most patients experiencing a significant improvement in quality of life."

Personalized Treatment Plans are Key, Preventive Measures Also Essential

The expert team at TreeENT emphasizes that rhinitis treatment requires personalized plans based on the patient's symptom type, severity, and lifestyle habits. Furthermore, during seasonal transitions and periods of high viral activity, rhinitis patients should pay special attention to protection: wearing masks outdoors to reduce cold air and virus exposure, maintaining appropriate indoor humidity, regularly cleaning air conditioner filters, and getting timely flu vaccinations.

With advances in medical technology, rhinitis has shifted from "incurable" to "manageable and treatable." Hong Kong residents should seek comprehensive evaluation from professional rhinologists to select the most suitable treatment plan, bid farewell to the burden of perennial rhinitis, and regain the right to breathe freely.